U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.736_741delinsTGTGTGTGAAG (p.Pro246_Pro247delinsCysValTer) AND not provided

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Dec 1, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000235196.15

Allele description [Variation Report for NM_000535.7(PMS2):c.736_741delinsTGTGTGTGAAG (p.Pro246_Pro247delinsCysValTer)]

NM_000535.7(PMS2):c.736_741delinsTGTGTGTGAAG (p.Pro246_Pro247delinsCysValTer)

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.736_741delinsTGTGTGTGAAG (p.Pro246_Pro247delinsCysValTer)
Other names:
p.Pro246Cysfs*3
HGVS:
  • NC_000007.14:g.5997388_5997393delinsCTTCACACACA
  • NG_008466.1:g.16714_16719delinsTGTGTGTGAAG
  • NM_000535.7:c.736_741delinsTGTGTGTGAAGMANE SELECT
  • NM_001322003.2:c.331_336delinsTGTGTGTGAAG
  • NM_001322004.2:c.331_336delinsTGTGTGTGAAG
  • NM_001322005.2:c.331_336delinsTGTGTGTGAAG
  • NM_001322006.2:c.736_741delinsTGTGTGTGAAG
  • NM_001322007.2:c.418_423delinsTGTGTGTGAAG
  • NM_001322008.2:c.418_423delinsTGTGTGTGAAG
  • NM_001322009.2:c.331_336delinsTGTGTGTGAAG
  • NM_001322010.2:c.331_336delinsTGTGTGTGAAG
  • NM_001322011.2:c.-198_-193delinsTGTGTGTGAAG
  • NM_001322012.2:c.-198_-193delinsTGTGTGTGAAG
  • NM_001322013.2:c.163_168delinsTGTGTGTGAAG
  • NM_001322014.2:c.736_741delinsTGTGTGTGAAG
  • NM_001322015.2:c.427_432delinsTGTGTGTGAAG
  • NP_000526.2:p.Pro246_Pro247delinsCysValTer
  • NP_001308932.1:p.Pro111_Pro112delinsCysValTer
  • NP_001308933.1:p.Pro111_Pro112delinsCysValTer
  • NP_001308934.1:p.Pro111_Pro112delinsCysValTer
  • NP_001308935.1:p.Pro246_Pro247delinsCysValTer
  • NP_001308936.1:p.Pro140_Pro141delinsCysValTer
  • NP_001308937.1:p.Pro140_Pro141delinsCysValTer
  • NP_001308938.1:p.Pro111_Pro112delinsCysValTer
  • NP_001308939.1:p.Pro111_Pro112delinsCysValTer
  • NP_001308942.1:p.Pro55_Pro56delinsCysValTer
  • NP_001308943.1:p.Pro246_Pro247delinsCysValTer
  • NP_001308944.1:p.Pro143_Pro144delinsCysValTer
  • LRG_161t1:c.736_741delCCCCCTinsTGTGTGTGAAG
  • LRG_161:g.16714_16719delinsTGTGTGTGAAG
  • NC_000007.13:g.6037019_6037024delinsCTTCACACACA
  • NM_000535.5:c.736_741delCCCCCTinsTGTGTGTGAAG
  • NM_000535.6:c.736_741delCCCCCTinsTGTGTGTGAAG
  • NR_136154.1:n.823_828delinsTGTGTGTGAAG
  • p.P246CfsX3
  • p.Pro246CysfsX3
Links:
OMIM: 600259.0015; dbSNP: rs267608150
NCBI 1000 Genomes Browser:
rs267608150
Molecular consequence:
  • NM_001322011.2:c.-198_-193delinsTGTGTGTGAAG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322012.2:c.-198_-193delinsTGTGTGTGAAG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NR_136154.1:n.823_828delinsTGTGTGTGAAG - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000535.7:c.736_741delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322003.2:c.331_336delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322004.2:c.331_336delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322005.2:c.331_336delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322006.2:c.736_741delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322007.2:c.418_423delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322008.2:c.418_423delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322009.2:c.331_336delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322010.2:c.331_336delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322013.2:c.163_168delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322014.2:c.736_741delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322015.2:c.427_432delinsTGTGTGTGAAG - nonsense - [Sequence Ontology: SO:0001587]
Observations:
6

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000149612GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Dec 11, 2020)
germlineclinical testing

Citation Link,

SCV001470606Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Pathogenic
(Apr 27, 2022)
unknownclinical testing

PubMed (7)
[See all records that cite these PMIDs]

SCV002586166CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Pathogenic
(Dec 1, 2023)
germlineclinical testing

Citation Link,

SCV004227262Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 27, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes5not providednot providednot providednot providedclinical testing
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Citations

PubMed

Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process.

Salvador MU, Truelson MRF, Mason C, Souders B, LaDuca H, Dougall B, Black MH, Fulk K, Profato J, Gutierrez S, Jasperson K, Tippin-Davis B, Lu HM, Gray P, Shah S, Chao EC, Ghahramani N, Landsverk M, Gau CL, Chen D, Pronold M.

J Clin Oncol. 2019 Mar 10;37(8):647-657. doi: 10.1200/JCO.18.00696. Epub 2019 Jan 31.

PubMed [citation]
PMID:
30702970
PMCID:
PMC6494248

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A.

Gastroenterology. 2008 Aug;135(2):419-28. doi: 10.1053/j.gastro.2008.04.026. Epub 2008 May 2.

PubMed [citation]
PMID:
18602922
PMCID:
PMC2759321
See all PubMed Citations (10)

Details of each submission

From GeneDx, SCV000149612.13

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed in individuals with Lynch syndrome (LS) and LS-related cancers as well as in individuals with constitutional mismatch repair deficiency (CMMR-D) syndrome (Clendenning 2008, Senter 2008, Herkert 2011, Alexander 2016, Rosty 2016, Wang 2020); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Also known as c.736_741del6ins11; Not observed in large population cohorts (Lek 2016); This variant is associated with the following publications: (PMID: 20205264, 22577899, 18602922, 30702970, 16619239, 24323032, 18178629, 21376568, 20487569, 20093870, 26552419, 25856668, 26895986, 27037742, 22081473, 26845104, 26681312, 27601186, 28418444, 29485237, 28466842, 23733757, 16817031, 21204794, 20682701, 29790872, 30322717, 31992580, 31447099, 33193653, 32719484, 32773772)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001470606.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The PMS2 c.736_741delinsTGTGTGTGAAG (p.Pro246Cysfs*3) variant alters the translational reading frame of the PMS2 mRNA and causes the premature termination of PMS2 protein synthesis. This variant has been reported in the published literature in several individuals and families affected with a Lynch syndrome associated cancer and/or polyps (PMIDs: 18602922 (2008), 27435373 (2016), 28466842 (2017), 30702970 (2019)), as well as in an individual affected with CMMRD (PMID: 21376568 (2011)). Based on the available information, this variant is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV002586166.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided5not providednot providedclinical testingnot provided

Description

PMS2: PVS1, PS4:Moderate

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided5not providednot providednot provided

From Mayo Clinic Laboratories, Mayo Clinic, SCV004227262.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (5)

Description

PP4, PP5, PM2, PM3, PS4_moderate, PVS1

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Apr 15, 2024